Immunocore Holdings (IMCR) Cash from Operations (2023 - 2026)

Immunocore Holdings has disclosed Cash from Operations across 4 years of filings, most recently posting 13775000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 13775000.0, down 3266.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 24922000.0 (down 180.18% YoY), and the FY2025 annual result was 10712000.0, down 141.1% from the prior year.
• Cash from Operations came in at 13775000.0 for Q1 2026 at Immunocore Holdings, up from 32655000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 25964000.0 in Q2 2025 to a low of 32655000.0 in Q4 2025.
• The 4-year median for Cash from Operations is 45000.0 (2023), against an average of 347230.77.
• Across the five-year window, Cash from Operations surged 52060.0% in 2024 and tumbled 3266.67% in 2026, its largest moves.
• Immunocore Holdings' Cash from Operations stood at 17733000.0 in 2023, then gained by 21.33% to 13951000.0 in 2024, then plunged by 134.07% to 32655000.0 in 2025, then surged by 57.82% to 13775000.0 in 2026.
• The last three Cash from Operations figures came in at 13775000.0 (Q1 2026), 32655000.0 (Q4 2025), and 4456000.0 (Q3 2025), per Business Quant data.